CannabisNewsBreaks

WednesdayNov 03, 2021 1:38 pm

CannabisNewsBreaks – Marijuana Company of America Inc. (MCOA) Announces Plans to Launch VapeTV US

Marijuana Company of America (OTC: MCOA), a diversified holding company with operations and investments throughout the cannabis industry, today announced its entry into a non-binding letter of intent (“LOI”) for the formation of a new in-store advertising business to be called VapeTV US Inc. According to the update, MCOA's wholly owned distribution company, cDistro Inc., will own 25% of the VapeTV US business, partnering with VapeTV Ltd. of the United Kingdom and Jasleen Enterprises LLC, the owner of Vapor Maven. “We are excited to initiate the U.S. market version of the highly successful and lucrative VapeTV business,” said Mike Shaw,…

Continue Reading

WednesdayNov 03, 2021 12:53 pm

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Announces Strategic Engagement of MZ Group

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) today announced its engagement of international investor relations specialists MZ Group to lead a comprehensive strategic investor relations and financial communications program across all key markets. The partnership with MZ represents an investment in BevCanna’s go-forward growth strategy as the company rapidly accelerates its evolution into a diversified health and wellness company. “Cannabis is an emerging leader within the overall $4.5 trillion wellness market, with the product market projected to reach $90.4 billion by 2026, according to MarketsandMarkets,” said Ted Haberfield, chairman and president of MZ Group North America. “BevCanna leverages proprietary…

Continue Reading

WednesdayNov 03, 2021 11:43 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Expand Hypertension Clinical Program Through Most Ambitious Study to Date

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced a significant new study to expand its hypertension clinical program. In addition, the company provided updates on three ongoing human clinical studies evaluating its proprietary DehydraTECH-CBD for potentially treating hypertension and heart disease. “HYPER-H21-4 is the most ambitious study Lexaria has ever undertaken and is enabled from the successful outcomes from our other 2021 human hypertension studies,” said Lexaria CEO Chris Bunka in the news release. “Outcomes from this study could support Lexaria's goals related to pursuit of regulatory approvals for DehydraTECH-CBD for potential use as…

Continue Reading

WednesdayNov 03, 2021 11:17 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Files PCT Application for Treating Neurodegenerative Disease Using Rare Cannabinoid

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids, today announced its filing of an international patent application demonstrating neuroprotection and enhanced neuronal function using a rare cannabinoid for the potential treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s and others. The Patent Cooperation Treaty (“PCT”) application, entitled “Compositions and Methods for Treating Neuronal Disorders with Cannabinoids,” specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative diseases by providing neuroprotection in a population of affected neurons. Further, the PCT application demonstrates the subject cannabinoid compound can also be used…

Continue Reading

TuesdayNov 02, 2021 2:08 pm

CannabisNewsBreaks – Lift & Co. Expo 2021 to Shine the Spotlight on Surprises and Ah-Ha! Moments

Lift & Co. Expo, Canada’s No. 1 cannabis conference and trade show, has surprises in store for its upcoming event. The expo, slated to take place at the Metro Toronto Convention Centre from Nov. 18-21, 2021, is legendary for its high-energy, immersive experience. With the debut of the Lift Psychedelics Business Summit and the Lift Cannabis Business Conference and Lift & Co. Expo Industry & Consumer Days trade show rounding out the agenda, the highly anticipated event is raising the bar for this year’s return. “After a necessary hiatus last year, our team is overflowing with new attractions and innovations…

Continue Reading

MondayNov 01, 2021 12:58 pm

CannabisNewsBreaks – CWCBExpo New York to Showcase Industry Leaders, Dynamic Solutions for Entire Cannabis Ecosystem

CWCBExpo New York today announced details for its upcoming event to take place Nov. 4-6, 2021, at the Javits Center in New York City. According to the update, the recently appointed chair of New York’s Cannabis Control Board, Tremaine Wright, will make her first public presentation at CWCBExpo New York on Nov 4. In addition, on behalf of New York’s Governor Kathy Hochul, Lieutenant Governor Brian A. Benjamin will officially open CWCBExpo New York at its Nov. 4 “Ribbon Cutting Ceremony.” Also in attendance all three days at CWCBExpo New York will be members of the New York State Office…

Continue Reading

MondayNov 01, 2021 12:53 pm

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) on Target to Become House of Brands, Great Channel Partner

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) recently welcomed former U.S. Congressman and now public policy consultant Ryan Costello to its board of directors. Costello is expected to deepen RWB’s U.S.-based representation, which is key as federal policy on cannabis shifts. The company also announced that it has built a new production facility to good manufacturing practice (“GMP”) specifications in Florida as part of an effort to capitalize on the growing cannabis derivative market there. The Florida facility is built to accommodate the demand for edibles. “Red White & Bloom has built a branded capsule and rosin line…

Continue Reading

FridayOct 29, 2021 2:11 pm

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Eyes Expansion, Stands to Benefit from Recently Signed AB45

Green Hygienics Holdings (OTCQB: GRYN), an enterprise focused on the high-standard cultivation and processing of industrial hemp, is one company expected to gain from the newly signed Assembly Bill 45 (“AB45”), which is set to benefit companies that grow and produce industrial hemp. AB45 allows for hemp-derived cannabinoids, extracts and derivatives in food and dietary supplements. “The company grows its hemp in a controlled environment at its farm in California, which, with 824 acres and 392,000 square feet of greenhouse space, is the largest USDA Certified Organic Hemp for CBD farm in North America,” reads a recent article. “The company…

Continue Reading

FridayOct 29, 2021 2:01 pm

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Continues to Position Itself as Multistate Operator in Cannabis Sector

Hero Technologies (OTC: HENC) is focused on becoming fully licensed in Michigan as part of its ongoing commitment to position itself as a multistate operator in the cannabis sector. Its BlackBox Systems and Technologies LLC subsidiary fulfilled the requirements for step 1 prequalification approval for a Class C Medicinal Use cannabis license in Michigan and received step 1 prequalification approval for a Class C Adult-Use cannabis license. “With those approvals in hand, Hero Technologies and BlackBox are now beginning the next — and last — step in the process of obtaining licensing approval in Michigan: establishment use or full license…

Continue Reading

FridayOct 29, 2021 1:11 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Earns Coverage for DehydraTECH(TM)’s Potential Market Reach, Multiple Uses

Lexaria Bioscience Corp. (NASDAQ: LEXX) was recently part of coverage by Zacks Small-Cap Research analysts based on its market potential. Zacks, which focuses its coverage on small and micro-cap companies it regards as under-followed or under-valued by the broader market in an effort to benefit investors as well as worthy innovators, valued the company at $15 per share. The valuation was based on the company’s portfolio supporting Lexaria’s patented DehydraTECH(TM) consumption and the multiple potential uses of the technology. The technology is also relatively low-cost, with the capacity to produce up to 400,000 consumer packaged goods through existing manufacturer relationships.…

Continue Reading